【市場調査レポート】二次高シュウ酸尿症薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Secondary Hyperoxaluria Drug Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。二次高シュウ酸尿症薬のグローバル市場インサイト・予測（～2028年） / Global Secondary Hyperoxaluria Drug Market Insights, Forecast to 2028 / QY2207E09281資料のイメージです。

• レポートコード：QY2207E09281
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、118ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の二次高シュウ酸尿症薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に二次高シュウ酸尿症薬の世界市場のxxx％を占める「OTT薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の二次高シュウ酸尿症薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの二次高シュウ酸尿症薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの二次高シュウ酸尿症薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

二次高シュウ酸尿症薬のグローバル主要メーカーには、Nestle、Glaxosmithkline Plc、Bayer Ag、Now Foods、Solgar Inc.、Pharmavite、Infinitus (china)、Mission Pharmacal Company、Oyster Shell、Allena Pharmaceuticals, Inc.、Amway Corp.、Celebrate Vitamins、Entring, Llc、Nature's Bounty、Oxthera、Renew Life Formulas, Inc.、Synlogic、Tiensなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

二次高シュウ酸尿症薬市場は、種類と用途によって区分されます。世界の二次高シュウ酸尿症薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
OTT薬、処方薬

【用途別セグメント】
病院薬局、オンライン薬局、小売薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 二次高シュウ酸尿症薬製品概要
- 種類別市場（OTT薬、処方薬）
- 用途別市場（病院薬局、オンライン薬局、小売薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の二次高シュウ酸尿症薬販売量予測2017-2028
- 世界の二次高シュウ酸尿症薬売上予測2017-2028
- 二次高シュウ酸尿症薬の地域別販売量
- 二次高シュウ酸尿症薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別二次高シュウ酸尿症薬販売量
- 主要メーカー別二次高シュウ酸尿症薬売上
- 主要メーカー別二次高シュウ酸尿症薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（OTT薬、処方薬）
- 二次高シュウ酸尿症薬の種類別販売量
- 二次高シュウ酸尿症薬の種類別売上
- 二次高シュウ酸尿症薬の種類別価格
・用途別市場規模（病院薬局、オンライン薬局、小売薬局）
- 二次高シュウ酸尿症薬の用途別販売量
- 二次高シュウ酸尿症薬の用途別売上
- 二次高シュウ酸尿症薬の用途別価格
・北米市場
- 北米の二次高シュウ酸尿症薬市場規模（種類別、用途別）
- 主要国別の二次高シュウ酸尿症薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの二次高シュウ酸尿症薬市場規模（種類別、用途別）
- 主要国別の二次高シュウ酸尿症薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の二次高シュウ酸尿症薬市場規模（種類別、用途別）
- 主要国別の二次高シュウ酸尿症薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の二次高シュウ酸尿症薬市場規模（種類別、用途別）
- 主要国別の二次高シュウ酸尿症薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの二次高シュウ酸尿症薬市場規模（種類別、用途別）
- 主要国別の二次高シュウ酸尿症薬市場規模（トルコ、サウジアラビア）
・企業情報
Nestle、Glaxosmithkline Plc、Bayer Ag、Now Foods、Solgar Inc.、Pharmavite、Infinitus (china)、Mission Pharmacal Company、Oyster Shell、Allena Pharmaceuticals, Inc.、Amway Corp.、Celebrate Vitamins、Entring, Llc、Nature's Bounty、Oxthera、Renew Life Formulas, Inc.、Synlogic、Tiens
・産業チェーン及び販売チャネル分析
- 二次高シュウ酸尿症薬の産業チェーン分析
- 二次高シュウ酸尿症薬の原材料
- 二次高シュウ酸尿症薬の生産プロセス
- 二次高シュウ酸尿症薬の販売及びマーケティング
- 二次高シュウ酸尿症薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 二次高シュウ酸尿症薬の産業動向
- 二次高シュウ酸尿症薬のマーケットドライバー
- 二次高シュウ酸尿症薬の課題
- 二次高シュウ酸尿症薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Secondary Hyperoxaluria Drug Market
The global Secondary Hyperoxaluria Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, OTT Medicine accounting for % of the Secondary Hyperoxaluria Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Secondary Hyperoxaluria Drug market size is valued at US$ million in 2021, while the North America and Europe Secondary Hyperoxaluria Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Secondary Hyperoxaluria Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Secondary Hyperoxaluria Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Secondary Hyperoxaluria Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Secondary Hyperoxaluria Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Secondary Hyperoxaluria Drug market.
Global Secondary Hyperoxaluria Drug Scope and Market Size
Secondary Hyperoxaluria Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Secondary Hyperoxaluria Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
OTT Medicine
Prescription Medicine
Segment by Application
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
By Company
Nestle
Glaxosmithkline Plc
Bayer Ag
Now Foods
Solgar Inc.
Pharmavite
Infinitus (china)
Mission Pharmacal Company
Oyster Shell
Allena Pharmaceuticals, Inc.
Amway Corp.
Celebrate Vitamins
Entring, Llc
Nature’s Bounty
Oxthera
Renew Life Formulas, Inc.
Synlogic
Tiens
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Secondary Hyperoxaluria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTT Medicine
1.2.3 Prescription Medicine
1.3 Market by Application
1.3.1 Global Secondary Hyperoxaluria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Secondary Hyperoxaluria Drug Market Perspective (2017-2028)
2.2 Secondary Hyperoxaluria Drug Growth Trends by Region
2.2.1 Secondary Hyperoxaluria Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Secondary Hyperoxaluria Drug Historic Market Size by Region (2017-2022)
2.2.3 Secondary Hyperoxaluria Drug Forecasted Market Size by Region (2023-2028)
2.3 Secondary Hyperoxaluria Drug Market Dynamics
2.3.1 Secondary Hyperoxaluria Drug Industry Trends
2.3.2 Secondary Hyperoxaluria Drug Market Drivers
2.3.3 Secondary Hyperoxaluria Drug Market Challenges
2.3.4 Secondary Hyperoxaluria Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Secondary Hyperoxaluria Drug Players by Revenue
3.1.1 Global Top Secondary Hyperoxaluria Drug Players by Revenue (2017-2022)
3.1.2 Global Secondary Hyperoxaluria Drug Revenue Market Share by Players (2017-2022)
3.2 Global Secondary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Secondary Hyperoxaluria Drug Revenue
3.4 Global Secondary Hyperoxaluria Drug Market Concentration Ratio
3.4.1 Global Secondary Hyperoxaluria Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Secondary Hyperoxaluria Drug Revenue in 2021
3.5 Secondary Hyperoxaluria Drug Key Players Head office and Area Served
3.6 Key Players Secondary Hyperoxaluria Drug Product Solution and Service
3.7 Date of Enter into Secondary Hyperoxaluria Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Secondary Hyperoxaluria Drug Breakdown Data by Type
4.1 Global Secondary Hyperoxaluria Drug Historic Market Size by Type (2017-2022)
4.2 Global Secondary Hyperoxaluria Drug Forecasted Market Size by Type (2023-2028)
5 Secondary Hyperoxaluria Drug Breakdown Data by Application
5.1 Global Secondary Hyperoxaluria Drug Historic Market Size by Application (2017-2022)
5.2 Global Secondary Hyperoxaluria Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Secondary Hyperoxaluria Drug Market Size (2017-2028)
6.2 North America Secondary Hyperoxaluria Drug Market Size by Type
6.2.1 North America Secondary Hyperoxaluria Drug Market Size by Type (2017-2022)
6.2.2 North America Secondary Hyperoxaluria Drug Market Size by Type (2023-2028)
6.2.3 North America Secondary Hyperoxaluria Drug Market Share by Type (2017-2028)
6.3 North America Secondary Hyperoxaluria Drug Market Size by Application
6.3.1 North America Secondary Hyperoxaluria Drug Market Size by Application (2017-2022)
6.3.2 North America Secondary Hyperoxaluria Drug Market Size by Application (2023-2028)
6.3.3 North America Secondary Hyperoxaluria Drug Market Share by Application (2017-2028)
6.4 North America Secondary Hyperoxaluria Drug Market Size by Country
6.4.1 North America Secondary Hyperoxaluria Drug Market Size by Country (2017-2022)
6.4.2 North America Secondary Hyperoxaluria Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Secondary Hyperoxaluria Drug Market Size (2017-2028)
7.2 Europe Secondary Hyperoxaluria Drug Market Size by Type
7.2.1 Europe Secondary Hyperoxaluria Drug Market Size by Type (2017-2022)
7.2.2 Europe Secondary Hyperoxaluria Drug Market Size by Type (2023-2028)
7.2.3 Europe Secondary Hyperoxaluria Drug Market Share by Type (2017-2028)
7.3 Europe Secondary Hyperoxaluria Drug Market Size by Application
7.3.1 Europe Secondary Hyperoxaluria Drug Market Size by Application (2017-2022)
7.3.2 Europe Secondary Hyperoxaluria Drug Market Size by Application (2023-2028)
7.3.3 Europe Secondary Hyperoxaluria Drug Market Share by Application (2017-2028)
7.4 Europe Secondary Hyperoxaluria Drug Market Size by Country
7.4.1 Europe Secondary Hyperoxaluria Drug Market Size by Country (2017-2022)
7.4.2 Europe Secondary Hyperoxaluria Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Secondary Hyperoxaluria Drug Market Size (2017-2028)
8.2 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Type
8.2.1 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Secondary Hyperoxaluria Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Application
8.3.1 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Secondary Hyperoxaluria Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Region
8.4.1 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Secondary Hyperoxaluria Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Secondary Hyperoxaluria Drug Market Size (2017-2028)
9.2 Latin America Secondary Hyperoxaluria Drug Market Size by Type
9.2.1 Latin America Secondary Hyperoxaluria Drug Market Size by Type (2017-2022)
9.2.2 Latin America Secondary Hyperoxaluria Drug Market Size by Type (2023-2028)
9.2.3 Latin America Secondary Hyperoxaluria Drug Market Share by Type (2017-2028)
9.3 Latin America Secondary Hyperoxaluria Drug Market Size by Application
9.3.1 Latin America Secondary Hyperoxaluria Drug Market Size by Application (2017-2022)
9.3.2 Latin America Secondary Hyperoxaluria Drug Market Size by Application (2023-2028)
9.3.3 Latin America Secondary Hyperoxaluria Drug Market Share by Application (2017-2028)
9.4 Latin America Secondary Hyperoxaluria Drug Market Size by Country
9.4.1 Latin America Secondary Hyperoxaluria Drug Market Size by Country (2017-2022)
9.4.2 Latin America Secondary Hyperoxaluria Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Secondary Hyperoxaluria Drug Market Size (2017-2028)
10.2 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Type
10.2.1 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Secondary Hyperoxaluria Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Application
10.3.1 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Secondary Hyperoxaluria Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Country
10.4.1 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Secondary Hyperoxaluria Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Nestle
11.1.1 Nestle Company Details
11.1.2 Nestle Business Overview
11.1.3 Nestle Secondary Hyperoxaluria Drug Introduction
11.1.4 Nestle Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.1.5 Nestle Recent Developments
11.2 Glaxosmithkline Plc
11.2.1 Glaxosmithkline Plc Company Details
11.2.2 Glaxosmithkline Plc Business Overview
11.2.3 Glaxosmithkline Plc Secondary Hyperoxaluria Drug Introduction
11.2.4 Glaxosmithkline Plc Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.2.5 Glaxosmithkline Plc Recent Developments
11.3 Bayer Ag
11.3.1 Bayer Ag Company Details
11.3.2 Bayer Ag Business Overview
11.3.3 Bayer Ag Secondary Hyperoxaluria Drug Introduction
11.3.4 Bayer Ag Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.3.5 Bayer Ag Recent Developments
11.4 Now Foods
11.4.1 Now Foods Company Details
11.4.2 Now Foods Business Overview
11.4.3 Now Foods Secondary Hyperoxaluria Drug Introduction
11.4.4 Now Foods Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.4.5 Now Foods Recent Developments
11.5 Solgar Inc.
11.5.1 Solgar Inc. Company Details
11.5.2 Solgar Inc. Business Overview
11.5.3 Solgar Inc. Secondary Hyperoxaluria Drug Introduction
11.5.4 Solgar Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.5.5 Solgar Inc. Recent Developments
11.6 Pharmavite
11.6.1 Pharmavite Company Details
11.6.2 Pharmavite Business Overview
11.6.3 Pharmavite Secondary Hyperoxaluria Drug Introduction
11.6.4 Pharmavite Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.6.5 Pharmavite Recent Developments
11.7 Infinitus (china)
11.7.1 Infinitus (china) Company Details
11.7.2 Infinitus (china) Business Overview
11.7.3 Infinitus (china) Secondary Hyperoxaluria Drug Introduction
11.7.4 Infinitus (china) Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.7.5 Infinitus (china) Recent Developments
11.8 Mission Pharmacal Company
11.8.1 Mission Pharmacal Company Company Details
11.8.2 Mission Pharmacal Company Business Overview
11.8.3 Mission Pharmacal Company Secondary Hyperoxaluria Drug Introduction
11.8.4 Mission Pharmacal Company Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.8.5 Mission Pharmacal Company Recent Developments
11.9 Oyster Shell
11.9.1 Oyster Shell Company Details
11.9.2 Oyster Shell Business Overview
11.9.3 Oyster Shell Secondary Hyperoxaluria Drug Introduction
11.9.4 Oyster Shell Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.9.5 Oyster Shell Recent Developments
11.10 Allena Pharmaceuticals, Inc.
11.10.1 Allena Pharmaceuticals, Inc. Company Details
11.10.2 Allena Pharmaceuticals, Inc. Business Overview
11.10.3 Allena Pharmaceuticals, Inc. Secondary Hyperoxaluria Drug Introduction
11.10.4 Allena Pharmaceuticals, Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.10.5 Allena Pharmaceuticals, Inc. Recent Developments
11.11 Amway Corp.
11.11.1 Amway Corp. Company Details
11.11.2 Amway Corp. Business Overview
11.11.3 Amway Corp. Secondary Hyperoxaluria Drug Introduction
11.11.4 Amway Corp. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.11.5 Amway Corp. Recent Developments
11.12 Celebrate Vitamins
11.12.1 Celebrate Vitamins Company Details
11.12.2 Celebrate Vitamins Business Overview
11.12.3 Celebrate Vitamins Secondary Hyperoxaluria Drug Introduction
11.12.4 Celebrate Vitamins Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.12.5 Celebrate Vitamins Recent Developments
11.13 Entring, Llc
11.13.1 Entring, Llc Company Details
11.13.2 Entring, Llc Business Overview
11.13.3 Entring, Llc Secondary Hyperoxaluria Drug Introduction
11.13.4 Entring, Llc Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.13.5 Entring, Llc Recent Developments
11.14 Nature’s Bounty
11.14.1 Nature’s Bounty Company Details
11.14.2 Nature’s Bounty Business Overview
11.14.3 Nature’s Bounty Secondary Hyperoxaluria Drug Introduction
11.14.4 Nature’s Bounty Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.14.5 Nature’s Bounty Recent Developments
11.15 Oxthera
11.15.1 Oxthera Company Details
11.15.2 Oxthera Business Overview
11.15.3 Oxthera Secondary Hyperoxaluria Drug Introduction
11.15.4 Oxthera Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.15.5 Oxthera Recent Developments
11.16 Renew Life Formulas, Inc.
11.16.1 Renew Life Formulas, Inc. Company Details
11.16.2 Renew Life Formulas, Inc. Business Overview
11.16.3 Renew Life Formulas, Inc. Secondary Hyperoxaluria Drug Introduction
11.16.4 Renew Life Formulas, Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.16.5 Renew Life Formulas, Inc. Recent Developments
11.17 Synlogic
11.17.1 Synlogic Company Details
11.17.2 Synlogic Business Overview
11.17.3 Synlogic Secondary Hyperoxaluria Drug Introduction
11.17.4 Synlogic Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.17.5 Synlogic Recent Developments
11.18 Tiens
11.18.1 Tiens Company Details
11.18.2 Tiens Business Overview
11.18.3 Tiens Secondary Hyperoxaluria Drug Introduction
11.18.4 Tiens Revenue in Secondary Hyperoxaluria Drug Business (2017-2022)
11.18.5 Tiens Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Secondary Hyperoxaluria Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of OTT Medicine
Table 3. Key Players of Prescription Medicine
Table 4. Global Secondary Hyperoxaluria Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Secondary Hyperoxaluria Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Secondary Hyperoxaluria Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Secondary Hyperoxaluria Drug Market Share by Region (2017-2022)
Table 8. Global Secondary Hyperoxaluria Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Secondary Hyperoxaluria Drug Market Share by Region (2023-2028)
Table 10. Secondary Hyperoxaluria Drug Market Trends
Table 11. Secondary Hyperoxaluria Drug Market Drivers
Table 12. Secondary Hyperoxaluria Drug Market Challenges
Table 13. Secondary Hyperoxaluria Drug Market Restraints
Table 14. Global Secondary Hyperoxaluria Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Secondary Hyperoxaluria Drug Revenue Share by Players (2017-2022)
Table 16. Global Top Secondary Hyperoxaluria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Secondary Hyperoxaluria Drug as of 2021)
Table 17. Ranking of Global Top Secondary Hyperoxaluria Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Secondary Hyperoxaluria Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Secondary Hyperoxaluria Drug Product Solution and Service
Table 21. Date of Enter into Secondary Hyperoxaluria Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Secondary Hyperoxaluria Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Secondary Hyperoxaluria Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Secondary Hyperoxaluria Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Secondary Hyperoxaluria Drug Revenue Share by Application (2017-2022)
Table 29. Global Secondary Hyperoxaluria Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Secondary Hyperoxaluria Drug Revenue Share by Application (2023-2028)
Table 31. North America Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Secondary Hyperoxaluria Drug Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Secondary Hyperoxaluria Drug Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Secondary Hyperoxaluria Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Secondary Hyperoxaluria Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Secondary Hyperoxaluria Drug Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Secondary Hyperoxaluria Drug Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Secondary Hyperoxaluria Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Secondary Hyperoxaluria Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Secondary Hyperoxaluria Drug Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Secondary Hyperoxaluria Drug Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Secondary Hyperoxaluria Drug Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Secondary Hyperoxaluria Drug Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Secondary Hyperoxaluria Drug Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Secondary Hyperoxaluria Drug Market Size by Country (2023-2028) & (US$ Million)
Table 61. Nestle Company Details
Table 62. Nestle Business Overview
Table 63. Nestle Secondary Hyperoxaluria Drug Product
Table 64. Nestle Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 65. Nestle Recent Developments
Table 66. Glaxosmithkline Plc Company Details
Table 67. Glaxosmithkline Plc Business Overview
Table 68. Glaxosmithkline Plc Secondary Hyperoxaluria Drug Product
Table 69. Glaxosmithkline Plc Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 70. Glaxosmithkline Plc Recent Developments
Table 71. Bayer Ag Company Details
Table 72. Bayer Ag Business Overview
Table 73. Bayer Ag Secondary Hyperoxaluria Drug Product
Table 74. Bayer Ag Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 75. Bayer Ag Recent Developments
Table 76. Now Foods Company Details
Table 77. Now Foods Business Overview
Table 78. Now Foods Secondary Hyperoxaluria Drug Product
Table 79. Now Foods Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 80. Now Foods Recent Developments
Table 81. Solgar Inc. Company Details
Table 82. Solgar Inc. Business Overview
Table 83. Solgar Inc. Secondary Hyperoxaluria Drug Product
Table 84. Solgar Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 85. Solgar Inc. Recent Developments
Table 86. Pharmavite Company Details
Table 87. Pharmavite Business Overview
Table 88. Pharmavite Secondary Hyperoxaluria Drug Product
Table 89. Pharmavite Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 90. Pharmavite Recent Developments
Table 91. Infinitus (china) Company Details
Table 92. Infinitus (china) Business Overview
Table 93. Infinitus (china) Secondary Hyperoxaluria Drug Product
Table 94. Infinitus (china) Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 95. Infinitus (china) Recent Developments
Table 96. Mission Pharmacal Company Company Details
Table 97. Mission Pharmacal Company Business Overview
Table 98. Mission Pharmacal Company Secondary Hyperoxaluria Drug Product
Table 99. Mission Pharmacal Company Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 100. Mission Pharmacal Company Recent Developments
Table 101. Oyster Shell Company Details
Table 102. Oyster Shell Business Overview
Table 103. Oyster Shell Secondary Hyperoxaluria Drug Product
Table 104. Oyster Shell Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 105. Oyster Shell Recent Developments
Table 106. Allena Pharmaceuticals, Inc. Company Details
Table 107. Allena Pharmaceuticals, Inc. Business Overview
Table 108. Allena Pharmaceuticals, Inc. Secondary Hyperoxaluria Drug Product
Table 109. Allena Pharmaceuticals, Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 110. Allena Pharmaceuticals, Inc. Recent Developments
Table 111. Amway Corp. Company Details
Table 112. Amway Corp. Business Overview
Table 113. Amway Corp. Secondary Hyperoxaluria Drug Product
Table 114. Amway Corp. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 115. Amway Corp. Recent Developments
Table 116. Celebrate Vitamins Company Details
Table 117. Celebrate Vitamins Business Overview
Table 118. Celebrate Vitamins Secondary Hyperoxaluria Drug Product
Table 119. Celebrate Vitamins Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 120. Celebrate Vitamins Recent Developments
Table 121. Entring, Llc Company Details
Table 122. Entring, Llc Business Overview
Table 123. Entring, Llc Secondary Hyperoxaluria Drug Product
Table 124. Entring, Llc Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 125. Entring, Llc Recent Developments
Table 126. Nature's Bounty Company Details
Table 127. Nature's Bounty Business Overview
Table 128. Nature's Bounty Secondary Hyperoxaluria Drug Product
Table 129. Nature's Bounty Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 130. Nature's Bounty Recent Developments
Table 131. Oxthera Company Details
Table 132. Oxthera Business Overview
Table 133. Oxthera Secondary Hyperoxaluria Drug Product
Table 134. Oxthera Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 135. Oxthera Recent Developments
Table 136. Renew Life Formulas, Inc. Company Details
Table 137. Renew Life Formulas, Inc. Business Overview
Table 138. Renew Life Formulas, Inc. Secondary Hyperoxaluria Drug Product
Table 139. Renew Life Formulas, Inc. Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 140. Renew Life Formulas, Inc. Recent Developments
Table 141. Synlogic Company Details
Table 142. Synlogic Business Overview
Table 143. Synlogic Secondary Hyperoxaluria Drug Product
Table 144. Synlogic Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 145. Synlogic Recent Developments
Table 146. Tiens Company Details
Table 147. Tiens Business Overview
Table 148. Tiens Secondary Hyperoxaluria Drug Product
Table 149. Tiens Revenue in Secondary Hyperoxaluria Drug Business (2017-2022) & (US$ Million)
Table 150. Tiens Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Secondary Hyperoxaluria Drug Market Share by Type: 2021 VS 2028
Figure 2. OTT Medicine Features
Figure 3. Prescription Medicine Features
Figure 4. Global Secondary Hyperoxaluria Drug Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Pharmacy Case Studies
Figure 6. Online Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Secondary Hyperoxaluria Drug Report Years Considered
Figure 9. Global Secondary Hyperoxaluria Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Secondary Hyperoxaluria Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Secondary Hyperoxaluria Drug Market Share by Region: 2021 VS 2028
Figure 12. Global Secondary Hyperoxaluria Drug Market Share by Players in 2021
Figure 13. Global Top Secondary Hyperoxaluria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Secondary Hyperoxaluria Drug as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Secondary Hyperoxaluria Drug Revenue in 2021
Figure 15. North America Secondary Hyperoxaluria Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Secondary Hyperoxaluria Drug Market Size Market Share by Type (2017-2028)
Figure 17. North America Secondary Hyperoxaluria Drug Market Size Market Share by Application (2017-2028)
Figure 18. North America Secondary Hyperoxaluria Drug Market Size Share by Country (2017-2028)
Figure 19. United States Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Secondary Hyperoxaluria Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Secondary Hyperoxaluria Drug Market Size Market Share by Type (2017-2028)
Figure 23. Europe Secondary Hyperoxaluria Drug Market Size Market Share by Application (2017-2028)
Figure 24. Europe Secondary Hyperoxaluria Drug Market Size Share by Country (2017-2028)
Figure 25. Germany Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Secondary Hyperoxaluria Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Secondary Hyperoxaluria Drug Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Secondary Hyperoxaluria Drug Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Secondary Hyperoxaluria Drug Market Size Share by Region (2017-2028)
Figure 35. China Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Secondary Hyperoxaluria Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Secondary Hyperoxaluria Drug Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Secondary Hyperoxaluria Drug Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Secondary Hyperoxaluria Drug Market Size Share by Country (2017-2028)
Figure 45. Mexico Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Secondary Hyperoxaluria Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Secondary Hyperoxaluria Drug Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Secondary Hyperoxaluria Drug Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Secondary Hyperoxaluria Drug Market Size Share by Country (2017-2028)
Figure 51. Turkey Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Secondary Hyperoxaluria Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Nestle Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 55. Glaxosmithkline Plc Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 56. Bayer Ag Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 57. Now Foods Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 58. Solgar Inc. Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 59. Pharmavite Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 60. Infinitus (china) Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 61. Mission Pharmacal Company Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 62. Oyster Shell Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 63. Allena Pharmaceuticals, Inc. Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 64. Amway Corp. Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 65. Celebrate Vitamins Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 66. Entring, Llc Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 67. Nature's Bounty Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 68. Oxthera Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 69. Renew Life Formulas, Inc. Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 70. Synlogic Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 71. Tiens Revenue Growth Rate in Secondary Hyperoxaluria Drug Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

医薬品用二次包装機のグローバル市場インサイト・予測（～2028年）

Global Pharmaceutical Secondary Packaging Machine Market Insights, Forecast to 2028
QY2207E09973 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界の医薬品用二次包装機の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医薬品用二次包装機...

ナルコレプシー治療薬のグローバル市場インサイト・予測（～2028年）

Global Narcolepsy Treatment Drug Market Insights, Forecast to 2028
QY2207E09256 2022年7月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のナルコレプシー治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にナルコレプシー治...

経口ペプチド薬のグローバル市場インサイト・予測（～2028年）

Global Oral Peptide Drug Market Insights, Forecast to 2028
QY2207E10445 2022年7月 87Pages
新型コロナウイルス感染症のパンデミックにより、世界の経口ペプチド薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口ペプチド薬の世界市...

二次電子検出器（SED）のグローバル市場インサイト・予測（～2028年）

Global Secondary Electron Detector (SED) Market Insights, Forecast to 2028
QY2207E08140 2022年7月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界の二次電子検出器（SED）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に二次電子検出...

経口用新型コロナウイルス感染症治療剤のグローバル市場インサイト・予測（～2028年）

Global Oral COVID-19 Drug Market Insights, Forecast to 2028
QY2207E10438 2022年7月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界の経口用新型コロナウイルス感染症治療剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

オンライン医薬品小売チェーンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Online Drug Retail Chain Market The global Online Drug Retail Chain market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Prescription Drugs a…
配合滅菌製剤薬局のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Compounded Sterile Preparations Pharmacy Market The global Compounded Sterile Preparations Pharmacy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this hea…
二次電子検出器（SED）のグローバル市場インサイト・予測（～2028年） A secondary electron detector (SED) for scanning electron microscopy offers images with resolution independent of the material. Market Analysis and Insights: Global Secondary Electron Detector (SED) Market Due to the COVID-19 pandemic, the global Secondary Electron Detector (SED) market size is esti…
経口ペプチド薬のグローバル市場インサイト・予測（～2028年） The drugs give through oral. Market Analysis and Insights: Global Oral Peptide Drug Market The global Oral Peptide Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Linac…
医薬品用二次包装機のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Pharmaceutical Secondary Packaging Machine Market Due to the COVID-19 pandemic, the global Pharmaceutical Secondary Packaging Machine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR …